Methods: This study was conducted at Franciscan St. Francis Health, a 500-bed community hospital with 30 medical ICU beds. This is a retrospective review of patients admitted to the medical ICU with a diagnosis of pneumonia between January 2014 - January 2016. Patients were divided into two groups: historical control group (pre-intervention-PRE) and post-protocol implementation (intervention group-INT). Baseline characteristics, cultures collected, days of antibiotic therapy, length of ICU stay, overall length of stay, mortality and 30 day readmission were compared.
Results:The PRE group included 134 patients and the INT group included 67 patients. Baseline characteristics between groups were similar. Average days of therapy were less in the INT compared to the PRE: ßeta-lactam, 6.72 ± 2.48 vs 7.37 ± 3.93; atypical, 4.25
Conclusion: Implementation of a pharmacist-driven protocol for treatment of pneumonia in a medical ICU reduced days of antibiotic therapy without increasing length of stay or mortality in this single-center study.
A. H. Stock, None
I. Shawa, None
R. Need, None
S. C. Cheatham, None